Filed: 11/13/2023ACC: 0000935836-23-000688
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $301.03M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$301.03M
Total AUM (reported)
67.47M
Total Shares
Allocation by class
COM$223.51M74.2%
COM NEW$41.59M13.8%
SPONS ADR$27.73M9.2%
SHS$8.20M2.7%
Portfolio Concentration
Top 3$141.52M47.0%
4–10$110.92M36.8%
11–25$48.59M16.1%
Top 3 weight
47.0%
Top 10 weight
83.9%
Voting Authority Distribution
Total shares with voting rights: 67.47M
Sole
Full voting authority
67.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
QUIDELORTHO CORP
SOLEShares658.79K
TypeSH
Market value$48.12M
15.98%
Sole
658.79K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares5.18M
TypeSH
Market value$47.34M
15.72%
Sole
5.18M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares2.52M
TypeSH
Market value$46.07M
15.30%
Sole
2.52M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares9.10M
TypeSH
Market value$32.59M
10.83%
Sole
9.10M
Shared
0.00
None
0.00
GALAPAGOS NV-SPON ADR
SOLEShares802.54K
TypeSH
Market value$27.73M
9.21%
Sole
802.54K
Shared
0.00
None
0.00
ALIMERA SCIENCES INC
SOLEShares3.98M
TypeSH
Market value$12.35M
4.10%
Sole
3.98M
Shared
0.00
None
0.00
MAXCYTE INC
SOLEShares3.76M
TypeSH
Market value$11.74M
3.90%
Sole
3.76M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.92M
TypeSH
Market value$11.00M
3.65%
Sole
5.92M
Shared
0.00
None
0.00
GAMIDA CELL LTD
SOLEShares7.97M
TypeSH
Market value$8.20M
2.73%
Sole
7.97M
Shared
0.00
None
0.00
ATYR PHARMA INC
SOLEShares4.63M
TypeSH
Market value$7.31M
2.43%
Sole
4.63M
Shared
0.00
None
0.00
SCYNEXIS INC
SOLEShares2.85M
TypeSH
Market value$6.50M
2.16%
Sole
2.85M
Shared
0.00
None
0.00
XOMA CORP
SOLEShares436.60K
TypeSH
Market value$6.15M
2.04%
Sole
436.60K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares5.27M
TypeSH
Market value$5.75M
1.91%
Sole
5.27M
Shared
0.00
None
0.00
ATEA PHARMACEUTICALS INC
SOLEShares1.72M
TypeSH
Market value$5.16M
1.71%
Sole
1.72M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares3.07M
TypeSH
Market value$4.06M
1.35%
Sole
3.07M
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares491.92K
TypeSH
Market value$3.94M
1.31%
Sole
491.92K
Shared
0.00
None
0.00
EXAGEN INC
SOLEShares1.20M
TypeSH
Market value$2.91M
0.97%
Sole
1.20M
Shared
0.00
None
0.00
IO BIOTECH INC
SOLEShares1.98M
TypeSH
Market value$2.79M
0.93%
Sole
1.98M
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares3.34M
TypeSH
Market value$2.78M
0.92%
Sole
3.34M
Shared
0.00
None
0.00
DELCATH SYSTEMS INC
SOLEShares686.24K
TypeSH
Market value$2.78M
0.92%
Sole
686.24K
Shared
0.00
None
0.00
ASSERTIO HOLDINGS INC
SOLEShares951.20K
TypeSH
Market value$2.44M
0.81%
Sole
951.20K
Shared
0.00
None
0.00
VANDA PHARMACEUTICALS INC
SOLEShares477.90K
TypeSH
Market value$2.06M
0.69%
Sole
477.90K
Shared
0.00
None
0.00
AYTU BIOPHARMA INC
SOLEShares472.37K
TypeSH
Market value$1.28M
0.42%
Sole
472.37K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
QUIDELORTHO CORPSOLE | COM | 658.79K | SH | $48.12M 15.98% | 658.79K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 5.18M | SH | $47.34M 15.72% | 5.18M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 2.52M | SH | $46.07M 15.30% | 2.52M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 9.10M | SH | $32.59M 10.83% | 9.10M | 0.00 | 0.00 |
GALAPAGOS NV-SPON ADRSOLE | SPONS ADR | 802.54K | SH | $27.73M 9.21% | 802.54K | 0.00 | 0.00 |
ALIMERA SCIENCES INCSOLE | COM NEW | 3.98M | SH | $12.35M 4.10% | 3.98M | 0.00 | 0.00 |
MAXCYTE INCSOLE | COM | 3.76M | SH | $11.74M 3.90% | 3.76M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.92M | SH | $11.00M 3.65% | 5.92M | 0.00 | 0.00 |
GAMIDA CELL LTDSOLE | SHS | 7.97M | SH | $8.20M 2.73% | 7.97M | 0.00 | 0.00 |
ATYR PHARMA INCSOLE | COM NEW | 4.63M | SH | $7.31M 2.43% | 4.63M | 0.00 | 0.00 |
SCYNEXIS INCSOLE | COM NEW | 2.85M | SH | $6.50M 2.16% | 2.85M | 0.00 | 0.00 |
XOMA CORPSOLE | COM NEW | 436.60K | SH | $6.15M 2.04% | 436.60K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 5.27M | SH | $5.75M 1.91% | 5.27M | 0.00 | 0.00 |
ATEA PHARMACEUTICALS INCSOLE | COM | 1.72M | SH | $5.16M 1.71% | 1.72M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 3.07M | SH | $4.06M 1.35% | 3.07M | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 491.92K | SH | $3.94M 1.31% | 491.92K | 0.00 | 0.00 |
EXAGEN INCSOLE | COM | 1.20M | SH | $2.91M 0.97% | 1.20M | 0.00 | 0.00 |
IO BIOTECH INCSOLE | COM | 1.98M | SH | $2.79M 0.93% | 1.98M | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 3.34M | SH | $2.78M 0.92% | 3.34M | 0.00 | 0.00 |
DELCATH SYSTEMS INCSOLE | COM NEW | 686.24K | SH | $2.78M 0.92% | 686.24K | 0.00 | 0.00 |
ASSERTIO HOLDINGS INCSOLE | COM NEW | 951.20K | SH | $2.44M 0.81% | 951.20K | 0.00 | 0.00 |
VANDA PHARMACEUTICALS INCSOLE | COM | 477.90K | SH | $2.06M 0.69% | 477.90K | 0.00 | 0.00 |
AYTU BIOPHARMA INCSOLE | COM | 472.37K | SH | $1.28M 0.42% | 472.37K | 0.00 | 0.00 |